To determine the potential clinical significance of EMP3 and PI3K/Akt and uPA/MMP-9 pathways, the tissue sections from clinical HCC patients were collected and applied to immunohistochemical (IHC) staining against these proteins. This evidence concerns the gene AKT1 and hepatocellular carcinoma.